By Chelsea Sheasley, Metro West Daily News
BOSTON – Legislators investigating the scandal involving a Framingham pharmaceutical compounding company heard varying accounts of a decision to reject stricter disciplinary action against the firm a decade ago, with pharmacy board members testifying the ruling was made by higher ups.
But public health officials said they are still investigating to find out who is responsible for the lenient treatment.
“It was presented as this is the decision that’s been made by people above us,” Karen Ryle, the secretary of the Massachusetts Board of Registration in Pharmacy, told a legislative panel on Wednesday.
Ryle, who served as chairman of the board in 2004, spoke at hearings called by Reps. David Linsky, D-Natick, Harold Naughton, D-Clinton, and Jeffrey Sanchez, D-Jamaica Plain, to examine the Department of Public Health’s oversight of the pharmacy industry in light of the national meningitis outbreak linked to NECC that has resulted in 32 deaths and 438 illnesses so far.
Continue reading here
No comments:
Post a Comment